Serum Institute Of India
Serum Institute Of India News
The Cyber Unit of Pune City police on Friday arrested three accused involved in the case
The Serum Institute of India and the Department of Biotechnology are set to launch India's first indigenously developed Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer on 1 September, official sources said.
A US delegation comprising Chargé D'Affaires Patricia Lacina, US Consul General in Mumbai Mike Hankey, CEO of Novavax Inc Stanley C Erck, and others visited SII headquarters in Pune and met its CEO Adar Poonawalla to celebrate 75 years of the US-India bilateral partnership
The country crossed a record 200 crore Covid-19 vaccinations on 17 July 2022 within barely 18 months of launching this exercise on 16 January last year
In August 2020, the US-based vaccine maker Novavax Inc had announced a licence agreement with SII for the development and commercialisation of NVX-CoV2373, its COVID-19 vaccine candidate
Serum Institute of India has written to the Centre seeking the inclusion of Covovax in the national COVID-19 vaccination programme in the interest of public health, official sources said on Wednesday.
The recommendation has been sent to Drugs Controller General of India (DCGI) for final approval
SII's CEO Adar Poonawalla said the vaccine is in line with Prime Minister Narendra Modi's 'vision of providing yet another vaccine to protect our children'
UK PM Boris Johnson, who is on a two-day visit in India, thanks Prime Minister Narendra Modi for a grand welcome in his home-state Gujarat on Thursday
He pointed out that there is rising vaccine fatigue among the public as the main reason for the low off-take of the vaccines even after the firm has massively slashed the price from Rs 600 to Rs 225 a dose
Couple moves Kerala High Court seeking Rs 10 crore compensation alleging daughter's death due to Covishield vaccine
As per the petition, the 19-year-old postgraduate student began feeling unwell a day after getting the Covishield vaccine and passed away on 12 August, 2021 exactly two weeks after she was administered the vaccine
The COVID-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and Moderna, said Adar Poonawalla
COVID-19: Indian vaccines sold in Europe for first time, says Adar Poonawalla; lauds Centre's work during pandemic
On 9 April, Poonawalla said in a tweet that SII had decided to revise the price of Covishield vaccine for private hospitals from Rs 600 to Rs 225 per dose
India's TB immunisation programme currently offers BCG vaccination at birth or as early as possible till one year of age
Novovax’s COVID-19 vaccine gets authorisation for 12-17 age group in India: What you should know about Covovax
The protein-based vaccine, which is about 90 per cent effective at preventing symptomatic coronavirus, received emergency-use approval from the Drugs Controller General of India
World number one tennis player Novak Djokovic was barred from participating in the Australian Open as he refused to get vaccinated against coronavirus
How conditional market authorisation to Covishield and Covaxin will change India’s COVID-19 vaccine drive
Highly-placed sources have said that the conditional market authorisation will now allow the two vaccines to be made available at private hospitals and clinics at pre-decided costs
The video emphasises the usefulness of the COVID-19 vaccine against the new virus variants.
The main focus of the research taking place in the Poonawalla Building will be vaccinology and it will house over 300 research scientists
After halting most overseas sales in March, Serum Institute will be dispatching the first new exports under the COVAX program for Tajikistan on Friday evening.